Tempus AI and Merck Expand Collaboration for Precision Medicine
Tempus AI (TEM) and Merck (MRK) announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomarkers and supporting Merck's oncology and potentially broader therapeutic portfolios. Under the terms of the agreement, Merck will use Tempus' de-identified data along with Tempus' Lens Platform and Workspaces environment.
